Skip to main content
OpenTrials

Clinical trial condition

Myeloproliferative Disorders

Explore clinical trials studying Myeloproliferative Disorders. Study availability and eligibility vary by location and protocol.

1,108 public trials 144 recruiting studies
Refine in advanced search Browse all conditions

Myeloproliferative Disorders trial results

Completed

Temozolomide and VNP40101M in Treating Patients With Relapsed or Refractory Leukemias

NCT00098436

Conditions
Blast Crisis, Bone Marrow Diseases, Carcinogenesis, +23 more
Locations
  • American Health Network - North Illinois Street Indianapolis, Indiana, United States
  • Duke Comprehensive Cancer Center Durham, North Carolina, United States
  • Case Comprehensive Cancer Center Cleveland, Ohio, United States
  • Cleveland Clinic Taussig Cancer Center Cleveland, Ohio, United States
View Trial Details
Completed

Treatment of Bone Marrow to Prevent Graft-Versus-Host Disease in Patients With Acute or Chronic Leukemia Undergoing Bone Marrow Transplantation

NCT00004255

Conditions
Anemia, Anemia, Refractory, Anemia, Refractory, with Excess of Blasts, +25 more
Locations
  • University of California San Diego Cancer Center La Jolla, California, United States
  • Presbyterian-St Luke's Medical Center Denver, Colorado, United States
  • Lombardi Cancer Center Washington D.C., District of Columbia, United States
  • Shands Hospital and Clinics, University of Florida Gainesville, Florida, United States
View all 15 locations
View Trial Details

Related conditions